Rocket Lab (RKLB) has completed its previously disclosed “at-the-market” equity offering program. On March 17, 2026, Rocket Lab filed a prospectus supplement with the U.S. Securities and Exchange ...

Regencell Bioscience ( (RGC)) just unveiled an update. On March 30, 2026, Regencell Bioscience filed a Form 6-K reporting that material documents were incorporated by reference into its effective ...

On March 19, 2026, the Staff of the Securities and Exchange Commission (“SEC”) issued Corporate Finance Interpretation (“CFI”) Question 116.26. The new guidance confirms that an S-3 issuer may ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

On March 19, 2026, the SEC issued guidance clarifying that a public company conducting an at‑the‑market (ATM) offering pursuant to a previously filed ATM prospectus supplement may sell the full amount ...

Strategy expanded its ability to raise capital via at‑the‑market equity and preferred offerings, adding new agents and adjusting stock authorization, allowing up to $44.1 billion in additional ...

Strategy launches new capital plan to buy more Bitcoin The company also bought more Bitcoin on Monday, worth billions Saylor turns equity markets into a Bitcoin accumulation engine Michael Saylor's ...

International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...

In case you've faced some hurdles solving the clue, Code for accessing an ATM, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, ...

The company revealed Tuesday morning that it has established the capacity to sell up to $300 million in common stock at its sole discretion. This program is pursuant to a shelf registration statement ...

OpenJDK project teams will focus work on features such as value types, code reflection, AOT compilation, and structured concurrency in the coming year. Oracle’s Java team in 2026 will work toward ...

Inhibikase Therapeutics ( (IKT)) has shared an announcement. On December 19, 2025, Inhibikase Therapeutics, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to ...